Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to consider and approve Audited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics has informed BSE that its Board of Directors will meet on Friday, May 16, 2025. The agenda includes considering and approving the audited standalone and consolidated financial results along with the Auditor's Report for the fourth quarter and full year ended March 31, 2025. The company will also consider other routine business matters. This is a standard regulatory intimation under SEBI Listing Regulations, with no actual financial numbers disclosed yet. The notice will also be uploaded on the company's website.
No immediate impact on shareholders as this is only a meeting notice. Investors should watch for the actual audited results on May 16, which could influence the stock depending on the numbers reported.